BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23317161)

  • 1. Computational peptidology: a new and promising approach to therapeutic peptide design.
    Zhou P; Wang C; Ren Y; Yang C; Tian F
    Curr Med Chem; 2013; 20(15):1985-96. PubMed ID: 23317161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-Peptide Interaction Design: PepCrawler and PinaColada.
    Zaidman D; Wolfson HJ
    Methods Mol Biol; 2017; 1561():279-290. PubMed ID: 28236244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational design of peptide ligands.
    Vanhee P; van der Sloot AM; Verschueren E; Serrano L; Rousseau F; Schymkowitz J
    Trends Biotechnol; 2011 May; 29(5):231-9. PubMed ID: 21316780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-peptide docking: opportunities and challenges.
    Ciemny M; Kurcinski M; Kamel K; Kolinski A; Alam N; Schueler-Furman O; Kmiecik S
    Drug Discov Today; 2018 Aug; 23(8):1530-1537. PubMed ID: 29733895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical and computational fragment-based approaches to targeting protein-protein interactions: applications in structure-guided drug discovery.
    Winter A; Higueruelo AP; Marsh M; Sigurdardottir A; Pitt WR; Blundell TL
    Q Rev Biophys; 2012 Nov; 45(4):383-426. PubMed ID: 22971516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Review on Current Advances in Peptide Drug Development and Design.
    Lee AC; Harris JL; Khanna KK; Hong JH
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplifying the Design of Protein-Peptide Interaction Specificity with Sequence-Based Representations of Atomistic Models.
    Zheng F; Grigoryan G
    Methods Mol Biol; 2017; 1561():189-200. PubMed ID: 28236239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the ideal properties for functional food peptides with antihypertensive effect? A computational peptidology approach.
    Zhou P; Yang C; Ren Y; Wang C; Tian F
    Food Chem; 2013 Dec; 141(3):2967-73. PubMed ID: 23871047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot-spot analysis for drug discovery targeting protein-protein interactions.
    Rosell M; Fernández-Recio J
    Expert Opin Drug Discov; 2018 Apr; 13(4):327-338. PubMed ID: 29376444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Peptide Ligation: Iterative Residue Docking and Linking as a New Approach to Predict Protein-Peptide Interactions.
    Diharce J; Cueto M; Beltramo M; Aucagne V; Bonnet P
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidomimetics Targeting Protein-Protein Interactions for Therapeutic Development.
    Zhang G; Andersen J; Gerona-Navarro G
    Protein Pept Lett; 2018; 25(12):1076-1089. PubMed ID: 30381055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Inhibition of the NCOA1/STAT6 Protein-Protein Interaction.
    Lee Y; Yoon H; Hwang SM; Shin MK; Lee JH; Oh M; Im SH; Song J; Lim HS
    J Am Chem Soc; 2017 Nov; 139(45):16056-16059. PubMed ID: 29090910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling peptide-protein interactions.
    London N; Raveh B; Schueler-Furman O
    Methods Mol Biol; 2012; 857():375-98. PubMed ID: 22323231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-Protein Docking in Drug Design and Discovery.
    Kaczor AA; Bartuzi D; Stępniewski TM; Matosiuk D; Selent J
    Methods Mol Biol; 2018; 1762():285-305. PubMed ID: 29594778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine Learning in Quantitative Protein-peptide Affinity Prediction: Implications for Therapeutic Peptide Design.
    Li Z; Miao Q; Yan F; Meng Y; Zhou P
    Curr Drug Metab; 2019; 20(3):170-176. PubMed ID: 30317994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis of LXXLL-mediated DAX1/SHP-nuclear receptor interaction network and rational design of stapled LXXLL-based peptides to target the specific network profile.
    Qian H; He P; Lv F; Wu W
    Int J Biol Macromol; 2019 May; 129():13-22. PubMed ID: 30731167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Integrated Computational Approaches in the Search for New Therapeutic Agents.
    Persico M; Di Dato A; Orteca N; Cimino P; Novellino E; Fattorusso C
    Mol Inform; 2016 Sep; 35(8-9):309-25. PubMed ID: 27546035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances and Computational Approaches in Peptide Drug Discovery.
    Maurya NS; Kushwaha S; Mani A
    Curr Pharm Des; 2019; 25(31):3358-3366. PubMed ID: 31544714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based identification of CaMKIIα-interacting MUPP1 PDZ domains and rational design of peptide ligands to target such interaction in human fertilization.
    Zhang YL; Han ZF; Sun YP
    Amino Acids; 2016 Jun; 48(6):1509-21. PubMed ID: 26984442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.